Damora Therapeutics Inc

{ "date": [ "202612", "202712", "202812", "202912" ], "revenue_estimate": [ null, null, null, null ], "ebit_estimate": [ -81.4, -116.94, -177.5, -255 ], "ebitda_estimate": [ -82.15, -85.57, null, null ], "net_income_estimate": [ -78.62, -112.41, -162, -254 ], "per_share_eps_estimate": [ -1.07, -1.48, -2.14, -2.53 ], "eps_nri_estimate": [ -1.07, -1.48, -2.14, -2.53 ], "dividend_estimate": [ null, null, null, null ], "book_value_per_share_estimate": [ 6.27, 5.4, null, null ], "pretax_income_estimate": [ -78.78, -112.41, -177, -254 ], "operating_cash_flow_per_share_estimate": [ -0.95, -0.92, null, null ], "roa_estimate": [ null, null, null, null ], "roe_estimate": [ -19.11, -15.86, null, null ], "gross_margin_estimate": [ null, null, null, null ], "operating_cash_flow_estimate": [ -32.58, -31.56, null, null ], "pettm_estimate": [ 0, 0, 0, 0 ], "long_term_growth_rate_mean": 0, "long_term_revenue_growth_rate_mean": "0.00", "future_per_share_eps_estimate_growth": null, "future_eps_nri_estimate_growth": null, "future_revenue_estimate_growth": null, "future_ebit_estimate_growth": null, "future_ebitda_estimate_growth": null, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": null, "future_pretax_income_estimate_growth": null, "future_book_value_per_share_estimate_growth": null, "future_roa_estimate_growth": null, "future_roe_estimate_growth": null, "future_gross_margin_estimate_growth": null, "future_operating_cash_flow_per_share_estimate_growth": null }

{ "date": [ "202606", "202609", "202612" ], "revenue_estimate": [ null, null, null ], "ebit_estimate": [ -21.22, -25.89, -27.63 ], "ebitda_estimate": [ null, null, null ], "net_income_estimate": [ -20.13, -24.36, -26.16 ], "per_share_eps_estimate": [ -0.26, -0.32, -0.34 ], "eps_nri_estimate": [ -0.26, -0.32, -0.34 ], "dividend_estimate": [ null, null, null ], "book_value_per_share_estimate": [ null, null, null ], "pretax_income_estimate": [ -20.13, -24.56, -26.36 ], "operating_cash_flow_per_share_estimate": [ null, null, null ], "roa_estimate": [ null, null, null ], "roe_estimate": [ null, null, null ], "gross_margin_estimate": [ null, null, null ], "operating_cash_flow_estimate": [ null, null, null ], "pettm_estimate": [ null, null, null ], "long_term_growth_rate_mean": 0, "long_term_revenue_growth_rate_mean": "0.00", "future_per_share_eps_estimate_growth": null, "future_eps_nri_estimate_growth": null, "future_revenue_estimate_growth": null, "future_ebit_estimate_growth": null, "future_ebitda_estimate_growth": null, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": null, "future_pretax_income_estimate_growth": null, "future_book_value_per_share_estimate_growth": null, "future_roa_estimate_growth": null, "future_roe_estimate_growth": null, "future_gross_margin_estimate_growth": null, "future_operating_cash_flow_per_share_estimate_growth": null }